Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan/Hydrochlorothiazide in moderate to severe hypertension
NCT00670566Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of irbesartan and hydrochlorothiazide in hypertension (HTN), sponsored by Sanofi. Primary endpoint: Number of patients with controlled blood pressure at 3 months. Started Apr 2008; status: completed.
02
Drugs
irbesartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00670566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670566.